共 11 条
[1]
Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO
[2]
2-9
[3]
Comparison of rheumatoid arthritis clinical trial outcome measures - A simulation study
[J].
ARTHRITIS AND RHEUMATISM,
2003, 48 (11)
:3031-3038
[4]
BOERS M, 1994, J RHEUMATOL, V21, P86
[5]
THE AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY CORE SET OF DISEASE-ACTIVITY MEASURES FOR RHEUMATOID-ARTHRITIS CLINICAL-TRIALS
[J].
ARTHRITIS AND RHEUMATISM,
1993, 36 (06)
:729-740
[6]
AMERICAN-COLLEGE-OF-RHEUMATOLOGY PRELIMINARY DEFINITION OF IMPROVEMENT IN RHEUMATOID-ARTHRITIS
[J].
ARTHRITIS AND RHEUMATISM,
1995, 38 (06)
:727-735
[7]
GOLDSMITH CH, 1993, J RHEUMATOL, V20, P561
[8]
An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the disease activity score (DAS) in a rheumatoid arthritis clinical trial
[J].
ARTHRITIS AND RHEUMATISM,
2003, 48 (03)
:625-630
[9]
Use of the American College of Rheumatology N(ACR-N) Index of improvement in rheumatoid arthritis - Argument in favor
[J].
ARTHRITIS AND RHEUMATISM,
2005, 52 (06)
:1637-1641